No Data
WUXI BIO issued 5.22 million shares of common stock according to the stock option plan.
WUXI BIO (02269) announced that on May 2, 2025, the company will issue 5.22 million ordinary shares to exercise Options according to the pre-IPO share option plan adopted on January 5, 2016 (revised on August 10, 2016).
Hong Kong Stock Morning Report | The U.S. actively conveyed information to China hoping to engage in talks, and May Day tourism sets another record.
① The USA proactively conveyed messages to China hoping to engage in talks, and China responded by stating it is currently evaluating. ② The USA's GDP decreased by an annualized rate of 0.3% in the first quarter, marking its first contraction since 2022. ③ The three major US stock indexes collectively fell on Monday, with mixed performances in Chinese stocks. ④ Buffett unexpectedly announced his resignation as CEO of Berkshire by the end of the year. ④ The "May Day" travel season has set a new record for the "most popular" in history.
WUXI BIO: Annual Report 2024
Guotou Securities: The investment and financing environment for Innovative Drugs is rebounding, CXO Orders and performance improvements are expected.
Global investment and financing in Innovative Drugs continues to improve, and a recovery in R&D demand is anticipated; new Orders are recovering in a timely manner, and there is optimism for improved CXO performance in 2025.
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
Accelerating recovery? In March, domestic Innovative Drugs investment and financing increased by about 50% year-on-year, and the Hong Kong Stock pharmaceutical Sector collectively surged.
① In March, domestic investment and financing for Innovative Drugs increased by approximately fifty percent year-on-year, how significant is the Bullish impact? ② The Hong Kong stock market's pharmaceutical Sector rose collectively, which stocks are attracting market attention?
